|
Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
 
|
5/2017
vol. 92 abstract:
Review paper
ReCOMmendations for management in cystic fibrosis for General PrActitionerS - COMPAS CF*
Dorota Sands
,
Katarzyna Walicka-Serzysko
,
Zbigniew Doniec
,
Agnieszka Mastalerz-Migas
,
Halina Batura-Gabryel
,
Władysław Pierzchała
PEDIATRIA POLSKA 92 (2017) 602-614
Online publish date: 2018/03/07
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
With the prolonged life, patients with cystic fibrosis require multi-specialty care including not only the treatment of the underlying disease but also its complications and associated diseases. Complications of bronchopulmonary disease, both infectious (fungal infections) and non-infectious (haemoptysis, pneumothorax, respiratory failure) are often a direct threat to life and require rapid identification and proper management. Dietary treatment aims to prevent malnutrition and disturbances of water-electrolyte management with cystic fibrosis characterized by metabolic alkalosis with hyponatremia and hypochloraemia (pseudo Bartter syndrome). At every stage of the disease, there are gastrointestinal complications that require special and appropriate treatment: from meconium ileus, through distal intestinal obstruction syndrome, reflux disease, pancreatitis and cystic fibrosis related diabetes or liver diseases. Patients with chronic inflammation and polyps of paranasal sinuses required laryngological care.The end of life is a time to choose whether to continue palliative treatment or to qualify for lung transplantation.
keywords:
COMPAS CF, Cystic fibrosis, Exocrine pancreatic insufficiency, Bronchopulmonary exacerbation, Lung transplantation |
POLSKI
